Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-operative Analgesic Efficacy of Ropivacaine in Colorectal and Hepatic Surgery
NCT01075646Phase 4Completed
- Sponsor
- Bellvitge University Hospital
- Start
- Mar 2009
- Primary completion
- Jun 2014
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by Bellvitge University Hospital. Primary endpoint: Mg of Morphine Consumption During 48 Hours Administered by Patient Controlled Analgesia System. Started Mar 2009; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01075646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01075646.